TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Biosite AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
143,929
|
129,357
|
122,126 |
Financial expenses |
108
|
3,333
|
7,001 |
Earnings before taxes |
22,031
|
10,701
|
14,150 |
EBITDA |
20,345
|
12,246
|
18,843 |
Total assets |
51,599
|
45,594
|
56,955 |
Current assets |
49,672
|
41,486
|
49,093 |
Current liabilities |
22,023
|
17,235
|
15,571 |
Equity capital |
25,022
|
23,364
|
35,889 |
- share capital |
101
![]() |
101
![]() |
101 |
Employees (average) |
16
|
20
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
48.5%
|
51.2%
|
63.0% |
Turnover per employee |
8,996
|
6,468
|
6,428 |
Profit as a percentage of turnover |
15.3%
|
8.3%
|
11.6% |
Return on assets (ROA) |
42.9%
|
30.8%
|
37.1% |
Current ratio |
225.5%
|
240.7%
|
315.3% |
Return on equity (ROE) |
88.0%
|
45.8%
|
39.4% |
Change turnover |
14,572
|
7,231
|
-100,174 |
Change turnover % |
11%
|
6% | |
Chg. No. of employees |
-4
|
1
|
-13 |
Chg. No. of employees % |
-20%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.